Clinical Trial Update: A Study for Schizophrenia Relapse Prediction

View source ↗

Summary

A Janssen-sponsored clinical trial evaluating relapse prediction in schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Schizophrenia | Status: COMPLETED